Coming News ???, page-297

do you mean the safety of the treatment? If so it’s been tested already and proven safe, which is why they could skip to phase 2/3. Otherwise, rem-l is acting to suppress the cytokine storms happening in a patient which is a condition where their own immune system is already majorly failing their body by attacking it. You cant really have more of a “negative immune system reaction” when the treatment’s target IS a negative immune system reaction. The results can either show improvement or more of the same (resulting in an unfortunate death)